Developing a cell and gene therapy packaging strategy

Introduction: Demand for viral vectors used for cell and gene therapies (CGT) is increasing dramatically as hundreds of these novel treatments advance through the clinic towards commercialization. Many challenges must be overcome to ensure the cost-effective manufacturing of these complex biomolecules, including selecting the right solutions for packaging, storage and transport of these expensive and potentially lifesaving products.

Best Practices • Storage • Transit